Sign in

CIK 0001641281 · <br>Emerging growth company

Bolt Biotherapeutics, Inc.

Sign in to watch
Ticker
BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472804636
Phone
650-665-9295
Business address
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Bolt Therapeutics, Inc.
Open-market buys, last 90 days
$319,000
in 1 filing
Open-market sales, last 90 days
$128,281
in 3 filings

Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Coastlands Capital LP +$319K 10% owner 1 filing
  2. Quinn William P. −$58K President, CEO and CFO sold 41% of stake
  3. Yonehiro Grant −$44K Chief Operating Officer sold 43% of stake
  4. Nemec Sarah −$26K Senior VP, Finance and PAO sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-09 HEALY JAMES Director Purchase +450,000 $20.00 $9.0M 2,754,437
2021-02-09 HEALY JAMES Director Conversion · Series C-1 Preferred Stock −1,104,209 0
2021-02-09 HEALY JAMES Director Conversion · Series C-2 Preferred Stock −1,200,228 0
2021-02-09 Khanna Ashish Siri Ram Director Purchase +1,000 $20.00 $20K 1,000
2021-02-09 Khanna Ashish Siri Ram Director Purchase +1,200 $20.00 $24K 1,200
2021-02-09 ENGLEMAN EDGAR Director Conversion +1,092,080 1,117,184
2021-02-09 ENGLEMAN EDGAR Director Conversion +317,922 1,435,106
2021-02-09 ENGLEMAN EDGAR Director Conversion +345,568 1,780,674
2021-02-09 ENGLEMAN EDGAR Director Option exercise +40,953 $0.07 $3K 1,821,627
2021-02-09 ENGLEMAN EDGAR Director Sale −144 $20.00 $3K 1,821,483
2021-02-09 ENGLEMAN EDGAR Director Purchase +175,733 $20.00 $3.5M 1,997,216
2021-02-09 ENGLEMAN EDGAR Director Conversion +150,802 154,268
2021-02-09 ENGLEMAN EDGAR Director Conversion +43,901 198,169
2021-02-09 ENGLEMAN EDGAR Director Conversion +47,718 245,887
2021-02-09 ENGLEMAN EDGAR Director Option exercise +5,655 $0.07 $396 251,542
2021-02-09 ENGLEMAN EDGAR Director Sale −20 $20.00 $400 251,522
2021-02-09 ENGLEMAN EDGAR Director Purchase +24,267 $20.00 $485K 275,789
2021-02-09 ENGLEMAN EDGAR Director Conversion · Series B Preferred Stock −1,092,080 0
2021-02-09 ENGLEMAN EDGAR Director Conversion · Series C- 1 Preferred Stock −317,922 0
2021-02-09 ENGLEMAN EDGAR Director Conversion · Series C- 2 Preferred Stock −345,568 0

Page 16 of 17 · 337 trades